Skip to main content
Erschienen in: Neurocritical Care 1/2022

Open Access 07.04.2022 | Original work

Sex-Related Differences in Patients’ Characteristics, Provided Care, and Outcomes Following Spontaneous Intracerebral Hemorrhage

verfasst von: Sophie Shih-Yüng Wang, Stefan Yu Bögli, Nathalie Nierobisch, Stella Wildbolz, Emanuela Keller, Giovanna Brandi

Erschienen in: Neurocritical Care | Ausgabe 1/2022

Abstract

Background

Sex-related differences in patients with spontaneous, non-traumatic intracerebral hemorrhage (ICH) are poorly investigated so far. This study elucidates whether sex-related differences in ICH care in a neurocritical care setting exist, particularly regarding provided care, while also taking patient characteristics, and outcomes into account.

Methods

This retrospective single center study includes all consecutive patients with spontaneous ICH admitted to the neurocritical care unit in a 10-year period. Patients’ demographics, comorbidities, symptoms at presentation, radiological findings, surgical and medical provided care, intensive care unit mortality and 12 month-mortality, and functional outcome at discharge were compared among men and women.

Results

Overall, 398 patients were included (male = 198 and female = 200). No differences in demographics, Charlson Comorbidity Index (CCI), symptoms at presentation, radiological findings, intensive care unit mortality and 12-month mortality were observed among men and women. Men received an external ventricular drain (EVD) for hydrocephalus-therapy significantly more often than women, despite similar location of the ICH and radiographic parameters. In the multivariate analysis, EVD insertion was independently associated with male sex (odds ratio 2.82, 95% confidence interval 1.61–4.95, P < 0.001) irrespective of demographic or radiological features. Functional outcome after ICH as assessed by the modified Rankin scale, was more favorable for women (P = 0.044).

Conclusions

Sex-related differences in patients with ICH regarding to provided neurosurgical care exist. We provide evidence that insertion of EVD is associated with male sex, disregarding clear reasoning. A sex-bias as well as social factors may play a significant role in decision-making for the insertion of an EVD.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Sex-differences in patients with stroke has already been the subject of several studies: Spontaneous intracerebral hemorrhage (ICH) incidence and prevalence has been described to be higher in men than in women, whereas women are older in age then man when spontaneous intracerebral hemorrhage (ICH) occurs [15]. Higher prevalence of tobacco and alcohol abuse in men have been discussed as a possible reason for this kind of disparity [3, 6]. On the contrary, subarachnoid hemorrhages and cardioembolic strokes, seem to affect more women than men [79]. The comparison of functional outcome between both sexes remains controversial with conflicting data without a clear sex with superior functional outcome, especially if adjusted for age [3, 6, 10]. Parameters of provided care (i.e., interventions, surgeries, medication, etc.) give relevant hints to uncover sex differences in certain pathologies. These aspects of provided care have not yet been thoroughly investigated in spontaneous non traumatic ICH. A better understanding of sex-related differences in patients with ICH may allow clinicians to more accurately advise patients and next-of-kin on the risks and benefits following ICH as well as counterbalance sex-bias in surgical and intensive care treatment.
The present single-center study investigates, whether sex-related differences regarding provided care, patients’ characteristics, and clinical outcomes in this particular cohort of patients with primary non traumatic ICH admitted to a neurocritical care unit exist in a retrospective manner.

Methods

This study was approved by the Ethical Committee in the Kanton of Zurich (IRB approval number KEK 2019-00.713). It was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. For this type of study, formal consent is not required. Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE) guidelines were used to draft the article.

Patients

All patients admitted to the neurocritical care unit of the University Hospital of Zurich between January 2009 and December 2019 with spontaneous ICH were eligible for inclusion in this retrospective study. Inclusion criteria of the study were (1) adults (aged > 18 years) and (2) presence of spontaneous ICH. Exclusion criteria were (1) patients’ written or documented oral refusal to have their data analyzed for research projects; (2) ICH secondary to cavernoma, dural arteriovenous fistula, other arteriovenous malformation, or histopathologically confirmed amyloidangiopathy (in autopsies and surgical biopsy during hematoma evacuation); (3) ICH of traumatic etiology; and (4) sole intraventricular hemorrhage with no parenchyma involvement. To rule out ICH of secondary genesis, computed tomography angiography is routinely performed in our department when the patient is admitted.

Data Collection

Data were obtained from the hospitals’ electronic health records (KISIM-TM; Cistec,® Zurich, Switzerland). Demographic data collected were: sex, age, height, weight, and presence of comorbidities, based on the Charlson Comorbidity Index (CCI) (i.e., history of myocardial infarction, congestive heart failure, peripheral vascular disease, history of cerebrovascular event, dementia, chronic pulmonary disease, rheumatologic disease, gastric ulcer, liver disease, diabetes without or with chronic complications, kidney disease, and history of cancer) [11]. Collected symptoms at presentation included hypertension (defined by a systolic blood pressure greater than 160 mmHg), headache, nausea and vomiting, and seizure at onset. Data concerning surgically provided care included insertion of an external ventricular drain (EVD), and surgical hematoma evacuation. At our institution the indication for EVD insertion is made by the treating neurosurgeon on the basis of imaging and their clinical expertise. Additionally, hematoma evacuation is performed by osteoplastic craniotomy only. Endoscopic evacuation is not commonly used at our institution. Moreover, primary decompressive craniectomy is not part of our institution’s treatment protocol. The following intensive care unit (ICU) complications were included: pneumonia (defined as new pulmonary infiltrate by chest X-ray, increased inflammatory blood parameters, and/or positive bacterial culture of tracheal secretion), clinical or electroencephalographic seizure, and blood- and/or platelets transfusion. Radiological findings on the initial cranial computer tomography (CT) scan included the main location of ICH, the presence of a spot sign, perifocal edema, subarachnoid hemorrhage, signs of ventriculomegaly (acute abnormal expansion of the cerebral ventricles), and hemorrhage volume. The hemorrhage volume was calculated using the formula of (abc)/2 (a = maximum length in mm, b = perpendicular width to a in mm, and c = number of slices multiplied by slice thickness in mm) from the initial CT scan. A neuroradiologist (NN) blinded to the clinical presentation and outcome evaluated all imaging. As outcome, ICU-length of stay (in days), hospital-length of stay (in days), mortality (30 days and 1 year after initial ICH), and functional outcome, as evaluated with the modified Rankin scale (mRS) at discharge were collected. Additionally, medical records and family interviews were then searched for indicators for early withdrawal of therapy (within 72 hours) and premorbid functional status (“independent” or “special care”) before the occurence of ICH and noted if it applied. “Independent” refers to autonomy in activities of daily living, life participation, social relationships and occupational performance if the patient is at pre-retirement age. “Special care” refers to any limitations in daily activities that make autonomous living at home impossible and require admission to a nursery home.

Statistical Analysis

Statistical analysis was performed using SPSS V.25. Descriptive statistics are reported as counts/percentages, mean ± standard deviation, or median and interquartile range, as appropriate. For the analysis of associations, patient characteristics were dichotomized depending on either sex or the insertion of an EVD, or the outcome (mRS score 0–3 vs. mRS 4–6). All continuous data were tested for normality using Shapiro–Wilk’s test. Categorical variables were compared using Pearson’s χ2 test or Fisher’s exact test. Continuous/ordinal variables compared using Student’s t-test or Mann–Whitney U-test for parametric and non-parametric data, respectively, as appropriate. Multivariate binomial logistic regression was performed to ascertain the independence of the associations found on the likelihood of insertion of EVD or on the likelihood of unfavorable outcome in the prior univariate analysis. Multivariate binomial logistic regression was performed to ascertain the independence of the associations found on the likelihood of insertion of EVD in the prior univariate analysis. Significance was defined as the probability of a two-sided type 1 error being < 5% (P < 0.05).

Results

Overall, 548 patients were admitted to the neurocritical care unit with International Classification of Diseases, 10th Revision code I.61 for ICH during the study period. Of those, 398 patients fulfilled the inclusion criteria (Fig. 1). Thereof, 198 were male (49%) and 200 (51%) were female. Demographic characteristics, presence of comorbidities, symptoms at presentation, and scores at admission are available in Table 1. No differences in age and symptoms at presentation between both sexes were observed. CCI score did not differ among sexes, but women more often suffered from rheumatic disease (P = 0.049), whereas men more likely had diabetes (P  = 0.001) and prior myocardial infarction (P = 0.003).
Table 1
Demographic data, initial clinical features, comorbidities
 
All (N = 398)
Female (N = 200)
Male (N = 198)
P-value
Age
66.14 ± 13.53
67.19 ± 13.52
65.09 ± 13.39
0.121
ICH score
1 (1, 2)
1 (1, 2)
1 (1, 2)
0.878
Initial GCS score
13 (8, 15)
13 (8, 15)
13 (8, 15)
0.782
Admission systolic blood pressure > 160 mmHg
139 (35%)
76 (38%)
63 (32%)
0.117
Initial headache
92 (23%)
44 (22%)
48 (24%)
0.504
Inital nausea and vomiting
106 (27%)
52 (26%)
54 (27%)
0.607
Seizure at onset
41 (10%)
18 (9%)
23 (12%)
0.312
History of tobacco use
70 (18%)
26 (13%)
44 (22%)
0.042
Anticoagulation use
91 (23%)
41 (20%)
50 (25%)
0.26
Charlson Comorbidity index score
1.78 ± 2.37
1.63 ± 1.86
1.93 ± 2.78
0.201
History of myocardial infarction
33 (9%)
8 (4%)
25 (13%)
0.003
Congestive heart failure
41 (10%)
21 (10%)
20 (10%)
1
Peripheral vascular disease
31 (8%)
11 (5%)
20 (10%)
0.127
History of cerebrovascular event
56 (14%)
27 (13%)
29 (15%)
0.918
Dementia
23 (6%)
12 (6%)
11 (6%)
1
Chronic pulmonary disease
36 (9%)
13 (6%)
23 (12%)
0.109
Rheumatologic disease
27 (7%)
19 (9%)
8 (4%)
0.049
Gastric ulcer
3 (1%)
1 (1%)
2 (1%)
0.993
Liver disease
12 (3%)
6 (3%)
6 (3%)
0.58
Diabetes (all)
69 (17%)
21 (10%)
48 (24%)
 < 0.001
Mild-moderate diabetes
48 (12%)
13 (6%)
35 (18%)
0.001
Diabetes with chronic complications
5 (1%)
2 (1%)
5 (3%)
0.438
Kidney disease
78 (20%)
38 (19%)
40 (20%)
0.861
History of Cancer
40 (10%)
27 (13%)
13 (7%)
0.054
Bold values indicate statistical significance at P < 0.05
Values are indicated as number (percentage) mean ± standard deviation, or median interquartile range
GCS Glasgow Coma Scale, ICH intracerebral hemorrhage

Radiological Findings

When we considered the hemorrhage site location, more women than men presented with lobar ICH (P = 0.007). Within lobar ICH, women were more likely to present with frontal and temporal ICH, and men presented more frequently with occipital hemorrhages. In addition, the frequency of deep ICH (basal ganglia or thalamus) did not differ among men and women (P = 0.224). Similarly, the frequency of the infratentorial ICH (e.g. brainstem or cerebellum) did not differ between sexes. Hemorrhage volume, hematoma expansion, presence of subarachnoid hemorrhage, ventriculomegaly, perifocal edema, intraventricular hemorrhage, and midline shift of parenchyma the ventricle on the first head CT-scan were not significantly different between groups (Table 2).
Table 2
Radiographic features
 
All (n = 398)
Female (n = 200)
Male (n = 198)
P-value
Ventriculomegaly
165 (41)
88 (44)
75 (38)
0.299
Subarachnoid hemorrhage
211 (53)
111 (55)
100 (51)
0.369
Perifocal edema
369 (91)
186 (93)
177 (89)
0.365
Hemorrhage volume (mL)
40.32 ± 47.71
39.32 ± 46.54
41.33 ± 48.96
0.675
Hematoma expansion
151 (38)
87 (44)
64 (32)
0.243
Midline shift parenchyma (mm)
7.87 ± 4.76
8 ± 4.77
7.71 ± 4.76
0.664
Midline shift ventricle (mm)
7.42 ± 4.76
7.49 ± 4.99
7.34 ± 4.49
0.823
Ventricular extension
246 (62)
124 (62)
122 (62)
0.97
Intraventricular hemorrhage including- third and fourth ventricle
178 (45)
93 (47)
85 (43)
0.482
Progredient ventricles
140 (35)
82 (41)
58 (29)
0.275
Localisation
   
0.007
 Deep
172 (43)
78 (45)
94 (55)
 
 Lobar
140 (35)
81 (58)
59 (42)
 
 Infratentorial
86 (22)
41 (48)
45 (52)
 
Deep
 
0.224
 Basal ganglia
112 (28)
48 (43)
64 (57)
 
 Thalamus
60 (15)
30 (50)
30 (50)
 
Lobar
   
0.002
 Frontal
43 (11)
30 (70)
13 (30)
 
 Parietal
40 (10)
19 (48)
21 (52)
 
 Temporal
39 (10)
25 (64)
14 (36)
 
 Occipital
18 (5)
7 (39)
11 (61)
 
Infratentorial
   
0.66
 Cerebellum
52 (13)
24 (46)
28 (54)
 
 Brainstem
34 (9)
17 (50)
17 (50)
 
Bold values indicate statistical significance at P < 0.05
Values are indicated as number and (percentage) and mean ± standard deviation, unless otherwise indicated

Provided Care

Even though, seizures at onset were not more prevalent in women, they received anti-epileptic drugs significantly more often than men (P = 0.007). Among the other conservative medical treatments (such as administration of blood and/or platelet conserves, frequency of intubation and days on mechanical ventilation), no differences were found among men and women (Table 3).
Table 3
Provided care and outcomes
 
All (n = 398)
Female (n = 200)
Male (n = 198)
P-value
EVD
112 (28)
45 (23)
67 (34)
0.016
Ventriculostomy related infection
13 (3)
4 (2)
9 (5)
0.153
Hematoma evacuation
90 (23)
49 (24)
41 (21)
0.433
EC given
32 (8)
16 (8)
16 (8)
1
TC given
61 (15)
33 (16)
28 (14)
0.51
Epilepsy during hospital stay
21 (5%)
13 (6%)
8 (4%)
0.28
Antiepileptic treatment
40 (10)
33 (16)
13 (7)
0.007
Intubation
173 (43)
88 (44)
85 (42)
0.75
Days on mechanical ventilation
4.63 ± 4.70
4.92 ± 5.46
4.38 ± 3.95
0.452
Pneumonia
88 (22%)
50 (25%)
38 (19%)
0.222
Length of ICU stay (days)
8.83 ± 21.22
6.93 ± 8.58
10.76 ± 28.74
0.073
Length of hospital stay (days)
15.08 ± 14.03
15.10 ± 12.97
15.05 ± 15.06
0.972
30 days mortaility
115 (29)
60 (30)
55 (28)
0.705
1 year mortality
142 (36)
73 (36)
69 (35)
0.575
Bold values indicate statistical significance at P < 0.05
Values are indicated as number (percentage) and mean ± standard deviation, unless otherwise indicated
EVD external ventricular drainage, EC Erythrocyte concentrate, ICU intensive care unit, TC Thrombocyte concentrate
When we considered surgical care, an EVD was inserted more often in men than in women (P-value = 0.016), whereas no differences were found in frequency of hematoma evacuation among men and women (P = 0.433) (Table 3). On the basis of the results of the univariate analysis evaluating differences depending on EVD insertion (Table 4), a multivariate analysis was performed (Table 5). Male sex, presence of intraventricular hemorrhage, ventriculomegaly, and volume as well as evacuation of ICH were independently associated with EVD insertion. Male sex in particular increased the odds of EVD insertion by 2.82 (95% confidence interval 1.61–4.95, P < 0.001).
Table 4
Univariate analysis dichotomized by EVD insertion
 
No EVD (n = 286)
EVD (n = 122)
P-value
Demographic data/clinical features
 Age
67.15 ± 13.91
63.58 ± 12.21
0.018
 Sex (male)
131 (45.8)
67 (59.8)
0.012
 ICH score
1 (1, 2)
2 (1, 2)
0.311
 Initial GCS score
13.5 (8.75, 15)
12 (6, 14)
0.008
 Admission systolic blood pressure > 160 mmHg
104 (36.4)
35 (31.3)
0.336
 Initial headache
67 (23.4)
25 (22.3)
0.814
 Inital nausea and vomiting
73 (25.5)
33 (29.7)
0.395
 Initial seizure
29 (10.2)
13 (11.8)
0.635
 Anticoagulation use
60 (21)
31 (28.6)
0.106
 Charlson Comorbidity index score
1 [0, 3]
2 [0, 3]
0.510
Radiographic features
 Ventriculomegaly
91 (31.8)
71 (63.4)
 < 0.001
 Subarachnoid hemorrhage
149 (52.1)
62 (55.4)
0.558
 Intraventricular hemorrhage
147 (51.4)
99 (88.4)
 < 0.001
 Intraventricular hemorrhage including- third fourth ventricle
91 (32)
87 (71)
 < 0.001
 Perifocal edema
260 (90.9)
102 (91.1)
0.960
 Initial hemorrhage volume
44.23 ± 52.85
30.34 ± 28.81
0.001
 Hematoma evacuation
49 (17.1)
41 (33.6)
 < 0.001
 Hematoma expansion
81 (32.5.)
35 (31.3)
0.810
 Midline shift parenchyma
148 (51.7)
63 (56.3)
0.418
 Ventricular progression
59 (23.6)
46 (41.1)
0.001
Localization
   
 Deep
96 (33.6)
72 (64.3)
 < 0.001
 Lobar
139 (45.1)
11 (9.8)
 < 0.001
 Infraten
61 (21.3)
29 (25.9)
0.328
 Deep
 Basal Ganglia
76 (26.6)
52 (46.4)
 < 0.001
 Thalamus
46 (16.1)
41 (36.6)
 < 0.001
Lobar
 Frontal
76 (26.6)
13 (11.6)
0.001
 Parietal
62 (21.7)
4 (3.6)
0.001
 Temporal
69 (24.1)
12 (10.7)
0.003
 Occipital
29 (10.1)
3 (2.7)
0.014
Infratentorial
 Cerebellum
38 (13.3)
22 (19.6)
0.111
 Brainstem
40 (14.0)
13 (10.7)
0.195
Bold values indicate statistical significance at P < 0.05
Values are indicated as number (percentage), mean ± standard deviation, or median and (interquartile range)
ICH intracerebral hemorrhage, GCS glasgow coma scale, EVD external ventricular drain
Table 5
Multivariate analysis
 
OR
95% CI
P-value
Age (per unit increase)
0.98
0.96–1.00
0.058
Sex (male as reference)
2.82
1.61–4.95
 < 0.001
Initial GCS score (per unit increase)
0.96
0.90–1.02
0.171
Ventriculomegaly (yes as reference)
2.94
1.63–5.32
 < 0.001
Volume hemorrhage (per mL increase)
0.98
0.97–0.99
 < 0.001
Hematoma evacuation (yes as reference)
7.97
3.70–17.17
 < 0.001
Intraventricular hemorrhage (yes as reference)
7.45
3.57–15.54
 < 0.001
Localization (deep/ lobar/ infratentorial)
1.25
0.83–1.87
0.288
Bold values indicate statistical significance at P < 0.05
GCS Glasgow Coma Scale
Data are presented as odds ratio (OR) with 95% confidence interval (95%CI)

Outcomes and Survival

Length of ICU-stay, length of hospital stay, 30 day- and 1 year- mortality did not differ between groups (Table 3). When we compared the outcome as evaluated using the mRS, men were more likely to suffer from an unfavorable outcome (Fig. 2). Further predictors of an unfavorable outcome at hospital discharge are shown in Tables 6 and 7. The multivariable analysis (Table 8) showed higher age, male sex, lower initial GCS score, midline shift, insertion of EVD, and higher CCI to be predictive of unfavorable outcome independent of TC transfusion, presence of ventriculomegaly, presence of intraventricular hemorrhage volume of hemorrhage and localization of the hematoma.
Table 6
Demographic data, initial clinical features, comorbidities, provided care depending on outcome
 
mRS 0–3 (n = 79)
mRS 4–6 (n = 319)
P-value
Age
63.00 ± 14.72
66.92 ± 13.13
0.021
Sex (Male)
31 (39)
167 (52)
0.044
ICH score
2 (1, 3)
2 (1, 3)
0.997
Initial GCS score
15 (14, 15)
12 (6, 14)
 < 0.001
Admission systolic blood pressure > 160 mmHg
27 (34)
112 (35)
0.896
Initial Headache
17 (22)
75 (24)
0.767
Inital nausea and vomiting
17 (22)
89 (28)
0.260
Initial seizure
10 (13)
32 (10)
0.538
History of tobacco use
16 (20)
54 (17)
0.510
Anticoagulation use
17 (22)
75 (24)
0.767
Charlson Comorbidity Index score
0 (0, 2)
2 (0, 3)
0.001
EVD
9 (11)
103 (32)
 < 0.001
Ventriculostomy-related infection
2 (3)
11 (3)
0.753
VP-shunt
0 (0.0)
18 (6)
0.030
Ventriculostomy-related infection
2 (3)
11 (3)
0.752
EC given
7 (9)
25 (8)
0.817
TC given
18 (23)
42 (13)
0.035
Antiepileptic treatment
7 (9)
39 (12)
0.440
Intubation
14 (18)
157 (49)
 < 0.001
Pneumonia
17 (22)
71 (22)
0.882
Length of ICU stay
4.96 ± 5.97
9.79 ± 23.43
0.070
Length of hospital stay
13.22 ± 10.33
15.54 ± 14.79
0.188
Bold values indicate statistical significance at P < 0.05
Values are indicated as number (percentage), mean ± standard deviation, or median (interquartile range)
EC erythrocyte concentrate, EVD external ventricular drain, GCS Glasgow Coma Scale, ICH intracerebral hemorrhage, ICU intensive care unit, mRS modified Rankin scale, TC thrombocyte concentrate
Table 7
Radiographic Features depending on outcome
 
mRS 0–3 (n = 79)
mRS 4–6 (n = 319)
P value
Ventriculomegaly
20 (25)
142 (45)
0.002
Subarachnoid hemorrhage
39 (49)
172 (54)
0.529
Intraventricular hemorrhage
38 (48)
208 (65)
0.006
Intraventricular hemorrhage including third fourth ventricle
25 (26)
153 (48)
0.011
Perifocal edema
65 (82)
297 (93)
0.005
Initial hemorrhage volume
20.30 ± 23.18
45.28 ± 50.85
 < 0.001
Hematoma evacuation
22 (28)
68 (21)
0.230
Hematoma expansion
19 (24)
97 (30)
0.167
Midline shift parenchyma
25 (32)
186 (58)
 < 0.001
Ventricular progression
13 (17)
92 (29)
0.010
Localisation
 Deep
10 (13)
158 (50)
 < 0.001
 Lobar
40 (51)
100 (31)
 < 0.002
 Infratentoriel
29 (37)
61 (19)
 < 0.001
Deep
 Basal ganglia
6 (8)
122 (38)
 < 0.001
 Thalamus
2 (3)
85 (27)
 < 0.001
Lobar
 Frontal
11 (14)
78 (25)
0.050
 Parietal
12 (15)
54 (17)
0.740
 Temporal
22 (28)
59 (19)
0.085
 Occipital
10 (13)
22 (7)
0.106
Infratentoriel
 Cerebellum
22 (28)
38 (12)
0.001
 Brainstem
9 (11)
43 (14)
0.769
Bold values indicate statistical significance at P < 0.05
Values are indicated as number (percentage) and mean ± standard deviation, unless otherwise indicated
mRS modified Rankin scale
Table 8
Multivariable analysis for unfavorable outcome
 
P-value
OR
95% C.I
Age (per unit increase)
0.002
1.04
1.01–1.06
Sex (male as reference)
0.012
2.19
1.19–4.03
Initial GCS score (per unit increase)
 < 0.001
0.74
0.65–0.84
CCI (per unit increase)
0.019
1.23
1.03–1.45
EVD (yes as reference)
0.002
4.19
1.73–10.17
TC given (yes as reference)
0.560
0.80
0.38–1.70
Ventriculomegaly (yes as reference)
0.458
0.76
0.37–1.57
Intraventricular hemorrhage (yes as reference)
0.686
1.14
0.60–2.17
Volume hemorrhage (per mL increase)
0.102
1.01
0.99–1.03
Midline shift parenchyma (yes as reference)
0.010
2.56
1.25–5.26
Localisation (deep/lobar/infratentoriel)
0.287
0.79
0.52–1.22
Bold values indicate statistical significance at P < 0.05
Data is presented as OR with 95%CI
CCI Charlson Comorbidity Index, CI confidence interval, EVD external ventricular drain, GCS Glasgow Coma Scale, OR odds ratio, TC thrombocyte concentrate
From all deceased patients n = 115, n = 55 (47,0%) died after early withdrawal of life-sustaining therapy. Of them n = 25 were men (45%) (P = 0.500 compared to female). Premorbid “special care” functional status was comparable in both sexes: n = 6 in women (20%) and n = 6 in men (24%) (P = 0.617).

Discussion

In our cohort of 398 consecutive patients admitted at the ICU following spontaneous ICH, we found that sex-related differences in outcome and provided care existed. In a multivariate analysis, male sex was independently associated with a poorer outcome, and insertion of EVD was significantly associated with male sex disregarding a clear radiographic or clinical reason. To the best of our knowledge, this difference in provided care (EVD insertion) is firstly reported in our study. We suggest that a gender-bias as well as social factors might have played a significant role in decision-making for the insertion of an EVD.
Patients’ demographics and severity scores at presentation and premorbid functional status were similar among men and women. Similarly, absolute CCI scores did not differ among groups. However, as reported in other studies, women more likely suffered from rheumatic disorders, whereas men were more likely to have diabetes and a history of myocardial infarction [1214]. Despite the similarities in demographics and presentation, men were almost three times as likely to receive an EVD in comparison with women. To understand the reasoning for this difference, we tested the hypothesis that men more frequently suffered from ICH in locations that were very difficult to be reached surgically (i.e., basal ganglia and the brain stem). In patients with such deep ICH, occlusive ventriculomegaly is very common, and the insertion of an EVD might represent the only surgical possibility to control the intracranial pressure. Interestingly, the frequency of deep as well as infratentorial ICH was similar among men and women. Additionally, radiographic signs for hydrocephalus (ventriculomegaly), intraventricular hemorrhage, and progression of ventricular size or ventricular shift–as well-known reasons for an EVD-insertion- were comparable among men and women. Therefore, we conducted a multivariate analysis with insertion of an EVD as outcome, and we found that male sex was independently associated with EVD insertion. Strikingly, even after correction for clinical and radiological features, male sex increased odds of EVD insertion by almost threefold. The same disparity did not apply to the incidence of surgical hematoma evacuation. Additionally, the frequency of limitation of life-sustaining therapy (early withdrawal within 72 hours) was comparable among men and women, and therefore it does not seem to be the reason for this observed difference in provided care in EVD placement.
We can only speculate if the reason for this discrepancy is a form of “gender-bias”. Previous studies, indeed, reported that not only patients’ sex but also physicians’ sex might play a role in the decision-making process in health care, showing a trend for less aggressive treatments for female patients [1517]. Women, furthermore, commonly have been shown to have less social support than men (often because more women are widowed) while older men are more likely to have a recognized representative (i.e. spouses, partners or children) when a decisions for an invasive medical treatment is necessary [18]. With the available data, we are not able to assess whether these factors, or also additional socioeconomic factors might have played a role in the decision to insert an EVD. The finding that females received anti-epileptic drugs significantly more often than males, despite a similar frequency of clinical or electroencephalographic seizures, also reveals a disposition to provide more conservative treatments for females in comparison to their male counterparts.
Despite the mentioned sex –related differences in provided care in favor of provided hydrocephalus-treatment by EVD in male patients, male sex was associated with significantly poorer outcome. Incidence of ventriculostomy-related infection was the same in both sexes, ruling out that this relevant EVD-related morbidity is causing poorer functional outcome in men. Previous findings concerning sex-related differences in mortality after ICH are conflicting: studies have reported that younger women (< 65 years old) with ICH had a lower mortality than men but also that women suffered from higher mortality and morbidity after ICH [19] [20]. In secondary ICH related to vascular abnormality, female sex was an independent risk factor for poor outcomes [21].
Concerning mortality, we did not observe that women fared worse than men did, probably because our study population differed from those in previous studies, with women not being older than men, suggesting that a combination of both sex and age may contribute to differences in outcome after ICH [10, 20]. Concerning functional outcome at hospital discharge after the ICH, however, female patients achieved a favorable outcome (mRS score 0–3) more often than male patients did, despite less aggressive treatment. This finding suggests that women could have had a favorable functional outcome even more likely, if they had received equal intensity of care as men. Although it is not possible to prove this by our study design, if we considered the efficacy of EVD in treating hydrocephalus, even more women might have had a favorable outcome had they received an EVD. However, because of due to the invasive nature of the treatment the opposite cannot be ruled out and an EVD insertion might carry unknown, outcome-relevant morbidity in men.

Strength and limitations of this Study

The strength of this study lies in the use of a database of consecutive patients with spontaneous ICH during a 10-year period with several parameters collected. However, due to the retrospective nature of our study, our study design bears limitations. Firstly, this is a single center study. Therefore, the generalizability of the results may be limited because we cannot exclude detection and referral biases. While most patients with severe clinical symptoms are admitted to the Neurocritical Care Unit in our institution, some may have also been admitted to the in-house intermediate care unit and thus, not been included in our study. Furthermore, while patients with histopathologically proven cerebral amyloid angiopathy were excluded, due to the small number of biopsies/autopsies we cannot exclude the possibility that some cases have still been included. Furthermore, MRIs were not regularly performed to screen for microbleeds. Moreover, the lack of data regarding the decision-making process of the neurosurgeon to insert an EVD only allows speculations about the reason of the sex-related discrepancy in frequency of EVD-insertion. Moreover, pre-admission status could only be recorded in a retrospective manner and not based on modified Rankin Scale. Due to the retrospective study design and unavailable data on the initial ICP or its course, the effect of EVD insertion on ICP management cannot be judged in this study design.

Conclusion

Sex-related differences in provided care of patients with spontaneous ICH exist. Men were almost three times more likely to receive an EVD in comparison with women. Neither demographical characteristics (including age and clinical presentation) nor imaging features (including ICH location, volume, and existence of ventriculomegaly) explained this discrepancy. These findings support the previously reported disposition to more aggressive treatments for men in comparison with women.

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This study was approved by the Ethical Committee in the Kanton of Zurich (IRB approval number KEK 2019-00.713).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Anästhesiologie

Kombi-Abonnement

Mit e.Med Anästhesiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes AINS, den Premium-Inhalten der AINS-Fachzeitschriften, inklusive einer gedruckten AINS-Zeitschrift Ihrer Wahl.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
2.
Zurück zum Zitat Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082–90.CrossRefPubMed Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082–90.CrossRefPubMed
4.
Zurück zum Zitat Sandset EC, et al. Sex differences in treatment, radiological features and outcome after intracerebral haemorrhage: pooled analysis of intensive blood pressure reduction in acute cerebral haemorrhage trials 1 and 2. Eur Stroke J. 2020;5(4):345–50.CrossRefPubMedPubMedCentral Sandset EC, et al. Sex differences in treatment, radiological features and outcome after intracerebral haemorrhage: pooled analysis of intensive blood pressure reduction in acute cerebral haemorrhage trials 1 and 2. Eur Stroke J. 2020;5(4):345–50.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Galati A, King SL, Nakagawa K. Gender disparities among intracerebral hemorrhage patients from a multi-ethnic population. Hawai’i J Med Public Health. 2015;74(9 Suppl 2):12–5. Galati A, King SL, Nakagawa K. Gender disparities among intracerebral hemorrhage patients from a multi-ethnic population. Hawai’i J Med Public Health. 2015;74(9 Suppl 2):12–5.
7.
Zurück zum Zitat Ghods AJ, Lopes D, Chen MJFIN. Gender differences in cerebral aneurysm location. Science. 2012;3:78. Ghods AJ, Lopes D, Chen MJFIN. Gender differences in cerebral aneurysm location. Science. 2012;3:78.
8.
Zurück zum Zitat Rosenørn J, Eskesen V, Schmidt KJBJON. Clinical features and outcome in females and males with ruptured intracranial saccular aneurysms. Science. 1993;7(3):287–90. Rosenørn J, Eskesen V, Schmidt KJBJON. Clinical features and outcome in females and males with ruptured intracranial saccular aneurysms. Science. 1993;7(3):287–90.
9.
Zurück zum Zitat Smith DB, et al. Gender differences in the Colorado stroke registry. Science. 2009;40(4):1078–81. Smith DB, et al. Gender differences in the Colorado stroke registry. Science. 2009;40(4):1078–81.
10.
Zurück zum Zitat Gokhale S, Caplan LR, James MLJS. Sex differences in incidence, pathophysiology, and outcome of primary intracerebral hemorrhage. Science. 2015;46(3):886–92. Gokhale S, Caplan LR, James MLJS. Sex differences in incidence, pathophysiology, and outcome of primary intracerebral hemorrhage. Science. 2015;46(3):886–92.
11.
Zurück zum Zitat D’Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49(12):1429–33.CrossRefPubMed D’Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49(12):1429–33.CrossRefPubMed
12.
Zurück zum Zitat Ji J, Sundquist J, Sundquist KJJOA. Gender-specific incidence of autoimmune diseases from national registers. J Clin Epidemiol. 2016;69:102–6. Ji J, Sundquist J, Sundquist KJJOA. Gender-specific incidence of autoimmune diseases from national registers. J Clin Epidemiol. 2016;69:102–6.
13.
Zurück zum Zitat Kaiser A, et al. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. J Clin Epidemiol. 2012;29(2):190–7. Kaiser A, et al. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. J Clin Epidemiol. 2012;29(2):190–7.
14.
Zurück zum Zitat Mannsverk J, et al. Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. Tromsø Study. 2012;19(5):927–34. Mannsverk J, et al. Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. Tromsø Study. 2012;19(5):927–34.
15.
Zurück zum Zitat Raine R, et al. Influence of patient gender on admission to intensive care. J Clin Epidemiol. 2002;56(6):418–23. Raine R, et al. Influence of patient gender on admission to intensive care. J Clin Epidemiol. 2002;56(6):418–23.
16.
Zurück zum Zitat Garrouste-Orgeas M, et al. Predictors of intensive care unit refusal in French intensive care units: a multiple-center study. J Clin Epidemiol. 2005;33(4):750–5. Garrouste-Orgeas M, et al. Predictors of intensive care unit refusal in French intensive care units: a multiple-center study. J Clin Epidemiol. 2005;33(4):750–5.
17.
Zurück zum Zitat Bugiardini R et al. (2014) Exploring in-hospital death from myocardial infarction in Eastern Europe: from the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC). In on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology. 2014. 12(6): p. 903–909 Bugiardini R et al. (2014) Exploring in-hospital death from myocardial infarction in Eastern Europe: from the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC). In on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology. 2014. 12(6): p. 903–909
18.
Zurück zum Zitat Hill A, et al. Examining mechanisms for gender differences in admission to intensive care units. J Clin Epidemiol. 2020;55(1):35–43. Hill A, et al. Examining mechanisms for gender differences in admission to intensive care units. J Clin Epidemiol. 2020;55(1):35–43.
19.
Zurück zum Zitat Ayala C, et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. J Clin Epidemiol. 2002;33(5):1197–201. Ayala C, et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. J Clin Epidemiol. 2002;33(5):1197–201.
20.
Zurück zum Zitat Craen A, et al. Gender differences in outcomes after non-traumatic intracerebral hemorrhage. J Clin Epidemiol. 2019;11(10):1008. Craen A, et al. Gender differences in outcomes after non-traumatic intracerebral hemorrhage. J Clin Epidemiol. 2019;11(10):1008.
21.
Zurück zum Zitat Hao Z, et al. Sex-specific differences in clinical characteristics and outcomes among patients with vascular abnormality-related intracerebral hemorrhage. J Clin Epidemiol. 2019;129:e669–76. Hao Z, et al. Sex-specific differences in clinical characteristics and outcomes among patients with vascular abnormality-related intracerebral hemorrhage. J Clin Epidemiol. 2019;129:e669–76.
Metadaten
Titel
Sex-Related Differences in Patients’ Characteristics, Provided Care, and Outcomes Following Spontaneous Intracerebral Hemorrhage
verfasst von
Sophie Shih-Yüng Wang
Stefan Yu Bögli
Nathalie Nierobisch
Stella Wildbolz
Emanuela Keller
Giovanna Brandi
Publikationsdatum
07.04.2022
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 1/2022
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-022-01453-y

Weitere Artikel der Ausgabe 1/2022

Neurocritical Care 1/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.